Effect of green tea extract on bone turnover markers in type 2 diabetic patients; A double- Blind, placebo-controlled clinical trial study

Daru

Volumn 17, Issue SUPPL. 1, 2009, Pages 38-44

  Mirzaei, K ^a   Hossein Nezhad, A ^a   Karimi, M ^b   Hosseinzadeh Attar, M J ^b   Jafari, N ^a   Najmafshar, A ^a   Larijani, B ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone turnover; Crosslaps; Green tea extraction; Osteocalcin; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; GLUCOSE; GREEN TEA EXTRACT; HEMOGLOBIN A1C; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSTEOCALCIN; PLACEBO;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; BONE STRUCTURE; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OSTEOLYSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WAIST HIP RATIO;

EID: 75449085699     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Maghbooli, Z., Hossein-Nezhad, A., Rahmani, M., Shafaei, A.R., Larijani, B. Relationship between leptin concentration and insulin resistance, Horm Metab Res, 2007; 39:903-907.
2. Maghbooli, Z., Hossein-Nezhad, A., Khoshniat, M., Adibi, H., Mohammadzadeh, N., Larijani, B., A study of bone mineral density in diabetic patients, Iranian Journal of Public Health, 2007;Suppl. 37-44
3. Herskind, A.M., Christensen, K., Norgaard-Andersen, K., Andersen, J.F. Diabetes mellitus and healing of closed fractures, Diabetes Metab, 1992;18:63-64.
4. Hofbauer, L., Brueck, C.C., Singh, S.K., Dobnig, H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res, 2007;22:1317-1328.
5. Mirzaei, K., Hossein-nezhad, A., Hosseinzadeh-Attar, M., Najmafshar, A., Jafari, N., Rahmani, M., Larijani, B.,Relationship between genotype and serum levels of adipokines and bone mineral density in type 2 diabetes mellitus patients, Iranian Journal of Diabetes and Lipid Disorders,2009; 77-86
6. Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro, Endocrinology, 1998;139:1329-1337.
7. Maghbooli, Z., Hossein-Nezhad, A., Nikoo, M.K., Shafei, A.R., Larijani, B., Bone marker status in mothers and their newborns in Iran, Journal of Maternal- Fetal & Neonatal Medicine, 2007;20 :639-643.
8. Suzuki, K., Kurose, T., Takizawa, M., Maruyama, M., Ushikawa, K., Kikuyama, M. Sugimoto, C., Seino, Y., Nagamatsu, S., Ishida, H. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclatogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral, Diabetes Res. Clin. Pract., 2005;68:117-125.
9. Epstein, S. Bone- derived proteins, Trends Endocr. Metab, 1989;1:9-14.
10. Ishida, H., Seino, Y., Takeshita, N., Kurose, T., Tsuji, K., Okamoto, Y. Someya, Y., Hara, K., Akiyama, Y., Imura, H. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin- induced diabetes, Acta Endocrinol. (Copenh.), 1992;127: 81-85.
11. Maghbooli, Z., Hossein-Nezhad, A., Karimi, F., Shafaei, A.R.,Larijani, B.,Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev,2008;24:27-32.
12. Suzuki, K., Kurose, T., Takizawa, M., Maruyama, M., Ushikawa, K., Kikuyama, M., Sugimoto, C., Seino, Y., Nagamatsu, S., Ishida, H., Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclatogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral, Diabetes Res. Clin. Pract. 68 (2005), pp. 117-125.
13. Eshaghi, S.M., Hossein-nezhad, A., Maghbooli, Z., Larijani,B., Relationship between Mandibular BMD and Bone Turnover Markers in Osteoporosis Diagnosis, Iranian Journal of Public Health, 2008; Suppl : 63-71.
14. Roudsari, A.H.Tahbaz, F., Hossein-Nezhad, A.,Arjmandi, B., Larijani, B.,Kimiagar, S.M., Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial,Nutr J, 2005 ;4:30.
15. Delaisse, J.M., Eeckhout, Y., Vaes, G. Inhibition of bone resorption in culture by (+)-catechin. Biochemical Pharmacology, 1986; 35:3091-3094.
16. Nakagawa, H., Wachi, M., Woo, J.T., 16. Kato, M., Kasai, S., Takahashi, F., Lee, I.S., Nagai, K. Fenton reaction is primarily involved in a mechanism of (3)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochemical & Biophysical Research Communications, 2002;292:94-101.
17. Yun, J.H., Kim, C.S., Cho, K.S., Chai J.K, Kim C.K, Choi S.H. (-)-Epigallocatechin gallate induces apoptosis, via caspase activation, in osteoclasts differentiated from RAW 264.7 cells. Journal of Periodontal Research, 2007;42:212-218.
18. Morinobu, A., Biao, W., Tanaka, S., 18. Horiuchi, M., Jun, L., Tsuji, G., Sakai, Y., Kurosaka, M., Kumagai, S.(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice. Arthritis and Rheumatism, 2008;58:2012-2018.
19. Vali, B., Rao, L.G., El-Sohemy, A. Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells. J Nutr Biochem, 2007;18:341-347.
20. Nakagawa, H., Wachi, M., Woo, J.T, Kato, M., Kasai, S., Takahashi, F., Lee, I.S., Nagai, K. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem Biophys Res Commun, 2002;292:94-101.
21. Islam, S., Islam, N., Kermode, T. 21. Johnstone, B., Mukhtar, H., Moskowitz, R.W., Goldberg, V.M., Malemud, C.J., Haqqi, T.M. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun, 2000;270:793-797.
22. Yun, J.H., Pang, E.K., Kim, C.S., Choi, S.H. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts. J Periodontal Res ,2004;39:300- 307.
23. Muraki, S., Yamamoto, S., Ishibashi, H., Oka, H., Yoshimura, N., Kawaguchi, H., Nakamura, K. Diet and lifestyle associated with increased bone mineral density: cross-sectional study of Japanese elderly women at an osteoporosis outpatient clinic. J Orthop Sci, 2007;12:317-320.
24. Shen, C.L., Wang, P., Guerrieri, J., Yeh, J.K., Wang, J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int., 2008;19:979-90.
25. Chen, C.H., Ho, M.L., Chang, J.K., Hung, S.H., Wang, G.J. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int., 2005;16:2039-2045.
26. Alberti, K.G., Zimmet, P.Z, Definition, diagnosis and classification of diabetes mellitus and its disorders. 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet. Med.1998,15,539-553.
27. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C.. Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia,1985; 28:412-419.
28. Narayan, K.M., Boyle, J.P., Thompson, T.J., Sorensen, S.W., Williamson, D.F. Lifetime risk for diabetes mellitus in the United States. JAMA, 2003 ;290. 1884-1890.
29. Hofbauer, L., Brueck, C.C., Singh, S.K., Dobnig, H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res, 2007;22:1317-1328.
30. Fukino. , Y., Ikeda, A., Maruyama, K., Aoki, N., Okubo, T., Iso, H.Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities, Eur. J. Clin. Nutr. ,2008;. 62 :953-960.
31. Ryu, O.H., Lee, J., Lee, K.W., Kim, H.Y., J.A. Seo, S.G. Kim, N.H. Kim, S.H. Baik, D.S. Choi and K.M. Choi, Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2-diabetes patients, Diabetes Res. Clin. Pract. 71 (2006), pp. 356-358.
32. Fukino, Y., Shimbo, M., Aoki, N., Okubo, T., Iso, H. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers, J. Nutr. Sci. Vitaminol. (Tokyo) , 2005;51:335-342.
33. Nuche-Berenguer, B., Moreno, P., Esbrit, P., Dapía, S., Caeiro, J.R., Cancelas, J., Haro-Mora, J.J., Villanueva-Peñacarrillo, M.L. Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States. ,Calcif Tissue Int. 2009 Feb 15.
34. Shen, C.L., Wang, P., Guerrieri, J., Yeh, J.K., Wang, J.S. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int,2008;19:979-990.
35. Botolin, S., McCabe, L,R. Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem, 2006; 99:411-424.
36. Manios, Y., Moschonis, G., Panagiotakos, D.B., Farajian, P., Trovas, G., Lyritis, G.P. Changes in biochemical indices of bone metabolism in post-menopausal women following a dietary intervention with fortified dairy products. J Hum Nutr Diet,2009;22:156-165.
37. Kanazawa, I., Yamaguchi, T., Yamamoto, M., Yamauchi, M., Kurioka, S., Yano, S., Sugimoto, T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab, 2009 94:45-9.
38. Islam, S., Islam, N., Kermode, T., Johnstone, B., Mukhtar, H., Moskowitz, R.W., Goldberg, V.M., Malemud, C.J., Haqqi, T.M. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res Commun,2000;270:793-797.
39. Sayinalp, S., Gedik, O., Koray, Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int, 1995;57:422-425.
40. Okazaki, R., Totsuka, Y., Hamano, K., Ajima, M., Miura, M., Hirota, Y., Hata, K., Fukumoto, S., Matsumoto, T. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J Clin Endocrinol Metab,1997;82:2915-2920.
41. Rosato, M.T., Schneider, S.H., Shapses, S.A. Bone turnover and insulin-like growth factor-1 levels increase after improved glycemic control in non insulin-dependent diabetes mellitus. Calcif Tissue Int, 1998;63:107-111.
42. Palacios, S., Castelo-Branco, C., Cifuentes, I., von Helde, S., Baro, L., Tapia-Ruano, C., Menendez, C., Rueda, C. Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial. Menopause, 2005;12: 63-68.